Perception of Smell and Taste During Antibiotic Treatment (OGUSTA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03893279|
Recruitment Status : Not yet recruiting
First Posted : March 28, 2019
Last Update Posted : March 29, 2019
Antibiotic use may be associated with effects on the perception of smell and taste. These effects are poorly known. The mechanisms can be very diverse, and the effect can be very variable depending on the type of antibiotic used, the dose, and the duration.
The aim of this study is to analyze the perception of the taste and olfactory capacities of patients, during an antibiotic treatment.
|Condition or disease||Intervention/treatment|
|Infectious Disease||Behavioral: Smell and Taste and questionnaire|
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||Perception of Smell and Taste During Antibiotic Treatment|
|Estimated Study Start Date :||April 2019|
|Estimated Primary Completion Date :||December 2021|
|Estimated Study Completion Date :||January 2022|
- Behavioral: Smell and Taste and questionnaire
The questionnaire must be completed before the antibiotic is taken, if a change of antibiotic is planned (stop of a treatment or addition of another treatment) and at the end of the antibiotic treatment.
- Questionnaire on Perception of taste [ Time Frame: Time of antibiotic treatment (maximum 6 months) ]
Collection of scores on perception of taste, during questionnaires to be completed before, during, and after taking antibiotics.
- Questionnaire on Perception of smell [ Time Frame: Time of antibiotic treatment (maximum 6 months) ]
Collection of scores on perception of smell, during questionnaires to be completed before, during, and after taking antibiotics.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03893279
|Contact: Tristan FERRY, Pr||04 72 07 24 81 ext +firstname.lastname@example.org|
|Department of Infectious and Tropical Diseases of the Croix Rousse Hospital of the Civil Hospitals of Lyon|
|Lyon, France, 69004|
|Contact: Tristan FERRY, Pr 04 72 07 24 81 ext +33 email@example.com|
|Principal Investigator: Tristan FERRY, Pr|